The Current Status on Systematic Reviews/Meta-analysis in Chinese Publications from 1990-2007

卫茂玲,刘鸣,苏维,牟焱明,李幼平
DOI: https://doi.org/10.3969/j.issn.1002-0179.2007.04.001
2007-01-01
Abstract:Objective:To investigate the current publication status of systematic reviews(SR)and meta-analysis by Chinese authors and to offer some information for it's further development in China.Methods:We used terms SR or meta-analysis to search the Chinese Biomedical Medicine database(CBM)(1979-2005)and Chinese National knowledge Infrastructure(CNKI)(1980-2007.4)in title and keywords and excluded those papers related duplication,translation,meeting information,simple literature evaluation,and protocol.Results:1.To Apr.2007,Chinese authors have published 1088 papers on SR or meta-analysis and there was an increase trend from 1990 to 2007.2.The authors' team was gradually developing and some of them with rich capabilities,one author had published 27 papers related traditional medicine and one author had co-published 43 papers on SR or meta-analysis.3.There were 364 papers on randomized controlled trials and 67 papers on non-randomized trials.46.1%(501/1088)was related to treatment,23.4%(254/1088)on prevention or risk factors,3.8%(41/1088)on diagnostic,and 1.8%(19/1088)on prognosis or rehabilitation.Conclusion:The number of papers on SR/Meta and their authors is gradually increased in past 18 years.However,it existed inappropriately using the methods of SR and meta-analysis and to some extent,not strictly followed regulated work manual.To improve the current meta-analysis of reviews' quality,Cochrane SR development manual might be the best option to follow during their reviews development.There was also need further researches on methods of non-randomized controlled trials and diagnostic trials to guide future practice.
What problem does this paper attempt to address?